NTRK1 and type 1 diabetes mellitus: This study has identified a novel signaling pathway involving activation of ErbB2 receptor tyrosine kinase and downstream signaling via ERK1/2 and ROCK as an important mediator of diabetes-induced vascular dysfunction in an experimental model of type 1 diabetes.